Comunicati Stampa
Salute e Benessere

LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

      Central to the system is the UbiqVue 2A Biosensor, a single-use, all-in-one wearable device that enables SpO 2 ** to be continuously collected from the chest, alongside other biodata, for generating a total of twelve monitored parameters, including 2-channel ECG, pulse rate, PPG, respiration rate, body temperature, and motion. The encrypted data is securely transmitted, in near real-time, from the Biosensor via a relay app or an access point to a secure cloud-based system, where it...
MILPITAS, Calif., (informazione.news - comunicati stampa - salute e benessere)

 

 

Central to the system is the UbiqVue 2A Biosensor, a single-use, all-in-one wearable device that enables SpO ** to be continuously collected from the chest, alongside other biodata, for generating a total of twelve monitored parameters, including 2-channel ECG, pulse rate, PPG, respiration rate, body temperature, and motion. The encrypted data is securely transmitted, in near real-time, from the Biosensor via a relay app or an access point to a secure cloud-based system, where it is further signal-processed. Healthcare professionals and care providers can access continuous vital signs, via the UbiqVue web portal, and receive alert notifications.

"This Class IIb EU MDR Certification, typically given to devices intended for the continuous surveillance of vital physiological parameters in anesthesia, intensive care or emergency care, confirms our commitment to deliver bedside patient monitor-equivalent functionality through an affordable, single-use Biosensor," said Surendar Magar , Co-founder and CEO. "By securing the necessary regulatory approvals in various geographies and creating global partnerships with OEMs, service providers, and distributors, we aim to transform healthcare at scale."

The UbiqVue System is expected to play a vital role in advancing both individual patient care and broader population health strategies, reinforcing LifeSignals' mission to deliver innovative, wireless solutions for healthcare systems worldwide. Learn more by visiting: https://www.lifesignals.com/ubiqvue-multiparameter/ 

** White light spectral SpO patented technology licensed from BioIntelliSense, Inc. LifeSignals, Inc. in partnership with BioIntelliSense, carried out the product-level design and processing technology enhancements enabling reliable, continuous SpO monitoring and accurate performance across all skin tones in a chest-worn Biosensor.

LifeSignals delivers scalable patient monitoring solutions for population health. Our UbiqVue Wireless Patient Monitoring System features single-use, multiparameter wearable Biosensors fully driven by proprietary system-on-chip silicon technology. This ready-to-deploy solution ensures seamless, accurate, and economical patient monitoring across clinical and community settings. Learn more at www.lifesignals.com.

Photo: https://mma.prnewswire.com/media/2573529/LifeSignals.jpg
Logo:  https://mma.prnewswire.com/media/2565377/5060887/LifeSignals_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/lifesignals-receives-eu-mdr-certification-for-ubiqvue-2a-multiparameter-system-302322766.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili